EQRx Revises Plans To Get Chinese Licensed Drugs To US Market

 
• By Jessica Merrill
  
U turn
EQRx is changing development plans for two drugs licensed from Chinese partners. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D